Transformation of mammary epithelial cells (MECs) from the normal to the neoplastic stage requires the dysregulation of tumor suppressor genes and protooncogenes. Tip30 is a tumor suppressor that can inhibit estrogen receptor-mediated transcription in MECs, but its role in MEC proliferation remains unknown. Here, we show that deleting the Tip30 gene leads to ductal hyperplasia in mouse mammary glands early in life and extensive mammary hyperplasia with age. Tip30 À/À mammary glands transplanted into wild-type mammary fat pads also display mammary trees with extensive ductal hyperplasia. Strikingly, Tip30 deletion promotes proliferation of primary MECs and results in rapid immortalization of MECs in vitro relative to wild-type cells. Gene array analysis identified significant increases in the expression of mammary epithelial growth factors Wisp2 and Igf-1 in Tip30 À/À cells. Knockdown of either Wisp2 or Igf-1 using short interfering RNA dramatically inhibited proliferation of Tip30 À/À cells. Together, these results suggest that Tip30 is an intrinsic and negative regulator of MEC proliferation partly through the inhibition of Wisp2 and Igf-1 expression, and its absence in the mammary gland may predispose MECs to neoplastic transformation.
Introduction
In the mammary gland, the progression of a cell from normal to neoplastic is a multi-step process. Experimental evidence suggests that mouse mammary epithelial cells (MECs) advance through a period of hyperplasia before becoming neoplastic (Medina and Kittrell, 1993; Medina, 2002) . This process is facilitated by genetic and epigenetic alterations of proto-oncogenes and tumor suppressor genes that regulate DNA repair, cell growth and apoptosis. As predicted from this concept, several genetically engineered mouse models with activation of a proto-oncogene, or inactivation of a tumor suppressor gene, show MEC hyperplasia occurring early in life, and mammary tumors arising stochastically after a long latency. For instance, mammary glands of Brca1 conditional mutant mice display hyperplastic lesions by 2-10 months of age, but no tumors; after 10-13 months, spontaneous mammary tumors develop (Xu et al., 1999) . However, other mouse models, such as the cdc25B transgenic and the P-cadherin and Caveolin-1 knockout models, exhibit mammary epithelial hyperplasia that does not progress to mammary tumor formation (Radice et al., 1997; Ma et al., 1999; Lee et al., 2002) . The development of hyperplasia before the appearance of mammary cancer suggests that additional genotypic changes are required for cancer progression. Thus, the identification of genes altered in preneoplasia will not only help us understand the molecular basis of mammary gland tumorigenesis but may also present potential diagnostic and chemopreventive targets for the treatment of human breast cancer.
Tip30, also called CC3, is a tumor suppressor that promotes apoptosis and inhibits angiogenesis (Shtivelman, 1997; Xiao et al., 1998) . Its expression is altered in human prostate, lung, colon and breast cancer (Hewitt et al., 2000; Varambally et al., 2002; Lee et al., 2004; Zhao et al., 2006) . Recent analysis of Tip30 expression in 87 breast cancer specimens suggests that its expression is inversely associated with metastasis (Zhao et al., 2006) . We previously reported that Tip30-deficient mice of C57BL6/J and 129SvJ mixed genetic background spontaneously develop tumors by 18-20 months of age (Ito et al., 2003) . The majority of these tumors occur in female mice, and many of them arise in estrogen-targeted organs (Ito et al., 2003) . However, the molecular mechanism by which Tip30 regulates tumorigenesis remains unidentified. A previous study suggested that Tip30 functions as an inhibitor of nuclear import (King and Shtivelman, 2004) in cells. Other studies implicated Tip30 as a transcription cofactor (Xiao et al., 1998; Jiang et al., 2004) . A recent study revealed that Tip30 interacts with an estrogen receptor (ER)-interacting coactivator, called CIA (coactivator independent of AF2), that is capable of both stimulation and repression of transcription (Jiang et al., 2004) . Tip30 can dynamically assemble on the promoter of c-Myc, an ER-target gene. Tip30 acts as a repressor in ERa-mediated transcription in both estrogen-dependent and independent manners (Jiang et al., 2004) .
Given the role of Tip30 in the regulation of ERmediated transcription (Jiang et al., 2004) , we investigated whether Tip30 played a role in the development and tumorigenesis of the mammary gland in Tip30-knockout mice. Our observations suggest that alteration of Tip30 expression may be an early event that contributes to the progression of MECs from the normal to the neoplastic state.
Results

Loss of Tip30 results in ductal hyperplasia in virgin mice early in life
We analysed the phenotypic consequences of Tip30 deficiency on mammogenesis in genetically engineered mice by examining whole-mount stained mammary glands from 5-and 8-week-old virgin Tip30 þ / þ and Tip30 À/À mice. At 5 weeks, Tip30 À/À glands appear to have more end terminal buds than their wild-type counterparts (Figures 1c and d) . At 8 weeks, ducts of Tip30 À/À glands penetrated the mammary fat pad similar to ducts in wild-type glands, indicating that Tip30 is not essential for ductal elongation (Figures 1a and b) . Although Tip30 À/À glands had a normal composition of epithelial cells with an extended lumen, ducts in (Figures 1f and h ). In addition, there is clear evidence of increased mitotic activity and individual necrotic epithelial cells characterized by nuclear karyorrhexis, cytoplasmic eosinophilic change and fragmentation, and association with occasional neutrophils (data not shown). Tip30 þ /À glands did not exhibit ductal hyperplasia observed in Tip30 À/À glands (data not shown). These results suggest that Tip30 loss results in ductal hyperplasia in mammary glands early in life.
Tip30-null mice have an increased incidence of alveolar bud formation in the mammary glands with age Given the hyperplasia we observed in 8-week-old virgin Tip30
À/À mice, we next sought to determine the effects of loss of Tip30 on the mammary glands of 1-year-old virgin mice. Whole mounts ( Figure 2a ) and histological sections (Figure 2c ) of glands of C57BL/6, 129SVJ or FVB/C57BL6 (25% FVB/75% C57BL/6) mixed background were scored for the presence of alveolar buds as defined by Cardiff et al. (2000) . For glands from all genetic backgrounds, 60-67% of the Tip30 À/À glands displayed a significantly increased number of alveolar buds as compared to wild-type glands (Figure 2b ). These data suggest that the loss of Tip30 increases the incidence of alveolar bud formation in the mammary glands of older virgin mice. Histological sections from Tip30 À/À glands showed an increased number of alveolar buds as compared to wild-type glands (Figure 2c ) and the presence of ductal hyperplasia. These data show that in addition to the ductal hyperplasia observed in 8-week-old Tip30-knockout mice, older virgin female Tip30-knockout mice also have an increased incidence of alveolar budding in the mammary glands.
Transplantation experiments demonstrate that Tip30's effects on the mammary gland are intrinsic To determine whether the observed effects of loss of Tip30 on the mammary glands were due to intrinsic genotypic and phenotypic changes in the mammary gland, pieces of mammary gland from 10-week-old Tip30 and mammary gland hyperplasia J Pecha et al transplanted Tip30 þ / þ glands (data not shown). There was also increased alveolar budding in the transplanted Tip30 À/À glands as compared to Tip30 þ / þ transplants (data not shown). In addition, the nodules of lymphocyte infiltration were observed near some blood vessels and ducts in both the wild-type and knockout transplanted glands (Figures 3c and d ), whereas they appeared larger in size and occurred much more frequently in the transplanted knockout glands (Figures 3d and e). This infiltration of lymphocytes around the ducts and blood vessels was also observed in the glands of untransplanted 1-year-old Tip30 À/À mice, but not in the glands of their wild-type littermates ( Figure 3e ). These results suggested that the effects of Tip30 deficiency on mammary gland alveolar morphology and ductal hyperplasia are intrinsic to the gland itself.
Loss of Tip30 increases MEC proliferation
To assess Tip30's role in MEC proliferation, we used in vivo 5-bromodeoxyuridine (BrdU) labeling in 8-weekold virgin Tip30 þ / þ and Tip30 À/À mice ( Figure 4a ). An increase (12%) in labeled MECs was observed in the Tip30 À/À glands, whereas few (1%) BrdU-labeled MECs were observed in wild-type glands. Additionally, apoptosis did not increase in Tip30-knockout glands as determined by the in situ TdT-mediated dNTP nick end labeling assay (data not shown). Thus, Tip30 À/À MECs are more proliferative than Tip30 þ / þ epithelial cells in vivo. To further verify this, we examined the effect of Tip30 loss on the growth of primary MECs in vitro.
MECs from virgin 8-week-old Tip30
À/À and Tip30
mice from the same litters were isolated and confirmed by in situ immunostaining of E-cadherin (data not shown), and their growth rates were compared. We found that Tip30 À/À cells grew much faster than Tip30 þ / þ cells as determined by both viable cell counting and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays (Figure 4b ). This result suggests that loss of Tip30 promotes proliferation of MECs.
Deletion of the Tip30 gene, a single step, results in a rapid immortalization of mouse MECs Mouse primary MECs in culture undergo crisis after 3-5 passages, during which time they expand very slowly. After crisis, which can last several weeks, immortalized cells, which proliferate readily, begin to appear (Medina and Kittrell, 2000) . While working with wild-type and Tip30-null MECs in culture, we observed that Tip30 À/À untransplanted mice. Tip30 þ / þ mammary glands from aged-matched mice do not exhibit the nodule of lymphocyte infiltration. *P value of o0.05 as determined by Student's t-test.
Tip30 and mammary gland hyperplasia J Pecha et al slowed dramatically after 9 days in culture (that is, seven population doublings, Figure 5b ), and after 16 days, ceased proliferating altogether for 4 weeks. After 7 weeks, immortalized clones began to arise; the growth rate of these post-crisis wild-type MECs was slower than the pre-crisis MECs until 2 additional weeks had passed. In contrast, Tip30 À/À MECs, while showing a decrease in population doublings during week 3 (that is, population doublings 9-10), did not stop proliferating for any length of time. At 2 weeks post-crisis, the Tip30 
Tip30 and mammary gland hyperplasia J Pecha et al
Of the 20 genes that had mRNA levels increase by more than 1.6-fold (Table 1) , the expression of two mammary gland growth factors, Wisp2 and Igf-1, was increased approximately 3.5-to 3.7-fold, respectively, in Tip30 To address whether increased Wisp2 or Igf-1 expression was responsible for the higher proliferative rate of Tip30 À/À MECs, short interfering RNA (siRNA) knockdown experiments were performed to target either Wisp2 or Igf-1 mRNA. Targeted siRNA reduced Wisp2 or Igf-1 mRNA levels by approximately 90% relative to Tip30 À/À cells treated with either transfection reagent only or with nonspecific siRNA, as determined by qRT-PCR (Figures 6b and c) . Moreover, Tip30
À/À MECs treated with either Wisp2 or Igf-1 siRNA had decreased cell numbers by 50-60% relative to control Tip30 À/À cells following a 3-day proliferation assay (Figure 6d ). These data suggest that both Igf-1 and Wisp2 play significant roles in the cell proliferative capacity of
Tip30
À/À cells, and that Tip30, in part, regulates MEC cell proliferation by directly or indirectly modulating the expression of Igf-1 and Wisp2.
Discussion
Tip30 is a negative regulator of MEC proliferation
We demonstrate here that the loss of Tip30 in the mammary glands of virgin mice leads to rapid immortalization of MECs in vitro and ductal hyperplasia in vivo. We also show that Tip30 À/À MECs proliferate faster than Tip30 þ / þ MECs both in vivo and ex vivo, as demonstrated by BrdU labeling, viable cell counting and MTT assays. Moreover, loss of Tip30 results in an increased incidence of alveolar budding and lymphocyte (unpublished data) . The low incidence of mammary tumors in these mice is not surprising given that C57BL6 mice are less susceptible to mammary tumorigenesis (Ullrich et al., 1996) . In addition, Tip30-knockout mice often die prematurely due to the development of lymphomas and other diseases, thereby possibly reducing the incidence of mammary tumors in Tip30-knockout mice.
Preneoplastic MECs may advance through stages of immortality and hyperplasia before becoming neoplastic (Medina and Kittrell, 1993; Medina, 2002) . The properties of immortality, hyperplasia and increased neoplastic potential have been demonstrated to be independent of one another. Characterization of four ductal mammary epithelial outgrowth lines by Medina and Kittrell (1993) showed these lines to be immortal, but morphologically normal and non-tumorigenic. Genes such as c-Myc, ZNF217 and Bmi-1, when overexpressed in vitro can immortalize human MEC (Wang et al., 1998; Nonet et al., 2001; Dimri et al., 2002) . Since loss of Tip30 results in increased expression of c-Myc in murine MECs (Jiang et al., 2004) , we propose that increased c-Myc expression could contribute to both the hyperplastic and immortal phenotypes in the mammary gland. Our microarray analysis of Tip30 þ / þ and Tip30 À/À MECs did not reveal elevated c-Myc expression as previously demonstrated in Tip30 þ / þ and Tip30 À/À mammary glands (Jiang et al., 2004) . This was likely due to the lack of estrogen in the culture medium used to grow wild-type and knockout MECs, thereby reducing the effects of Tip30 loss on estrogen-induced c-Myc expression (Jiang et al., 2004) . Therefore, deletion of Tip30 is able to contribute to both the immortality of MECs in ex vivo and hyperplasia of MECs in vivo. This could be due, in part, to the ability of Tip30 to repress c-Myc transcription as well as repress Wisp2 and Igf-1 expression. Consistent with this view, it was reported that knockdown of Wisp2 mRNA levels or the mRNA levels of components of the Igf-1 signaling pathway, such as 14-3-3 sigma protein, ERa, AIB1 (amplified in breast cancer 1), significantly reduces the proliferative capacity of MCF-7 breast cancer cells (Banerjee et al., 2003; Oh et al., 2004; Zhang et al., 2004 Zhang et al., , 2005 . Moreover, Wisp2 mRNA and protein expression is only detected in human breast cancer and not in normal human breast (Saxena et al., 2001) . The data presented herein suggest that Tip30 could play a significant role in regulating Igf-1 and/or Wisp2 expression. Thus, Tip30 is able to contribute to the appearance of two preneoplastic phenotypes, immortality and hyperplasia. It therefore may play an important role in the progression of MECs from normal to preneoplastic, and possibly predispose them to tumor formation.
In conclusion, our data provide the first evidence that Tip30 is a new negative factor in the regulation of MEC proliferation and may represent a novel signal pathway in the suppression of breast cancer development.
Materials and methods
Mice and MECs
The genetic background of Tip30
Tip30
À/À mice was regarded to be identical since they were backcrossed 10 times with C57BL/6 mice. Primary MECs of each genotype were prepared from 8-to 10-week-old mice and maintained in culture, as described previously (Medina and Kittrell, 2000) .
Cell culture
Cell growth by trypan blue exclusion A total of 3000 MECs of each genotype were seeded into 96-well plates and counted every other day in triplicate for 5 days using trypan blue dye.
Cell growth by MTT assay A total of 5000 MECs of each genotype were seeded into 24-well plates and cell viability measured every other day in triplicate for 5 days using MTT assay. Briefly, cells were incubated with 0.5 mg/ml MTT for 3 h at 371C, and absorbance was measured at 584 nm using a FLUOstar OPTIMA spectrophotometer.
Population doublings Population doublings were determined by plating MECs (5 Â 10 4 cells/well) in triplicate into six-well plates. When cells reached 80% confluency, they were counted and replated into new six-well plates (5 Â 10 4 cells/well). Population doublings were calculated by considering the number of cells at splitting and the number of times they had been passaged.
Estrous stage determination
Estrous cycle stage was determined by cytological evaluation of vaginal smears using the Protocol Hema 3 stain set (122-911, Fisher Scientific, Pittsburgh, PA, USA), according to the manufacturer's instructions.
Mammary transplantation
Pieces of 10-week-old wild-type and Tip30 À/À no. 4 mammary glands were transplanted individually into contralateral cleared fat pads of 21-day-old wild-type and Tip30 À/À mice (Shillingford et al., 2002) . Transplanted glands were harvested at 10 weeks or 1 year after transplantation.
Mammary whole mount, histology and BrdU labeling Whole mounts and BrdU labeling of mammary gland no. 4 were performed in 8-week virgin mice according to Rosen, Baylor College of Medicine (Houston, TX, USA) (http:// public.bcm.tmc.edu/rosenlab). Three to five mice of each qRT-PCR Standard curves were constructed using serial dilutions of plasmids containing the target sequence. qRT-PCR was performed using the Cepheid SmartCycle with SYBR green fluorescence detection as described in the Supplementary Materials and methods.
siRNA knockdown assays Target-specific siRNA for Igf-1 and Wisp2 and non-targeting siRNA (nonspecific control) were purchased from Dharmacon (Lafayette, CO, USA) and used at 100 nM concentrations according to the manufacturer's protocol. qRT-PCR and proliferation assays are described in the Supplementary Materials and methods.
